Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

3.490 -0.860 (-19.77%)

Streaming Delayed Price Updated: 1:23 PM EDT, Aug 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	838,325
Open	4.490
Bid (Size)	3.470 (100)
Ask (Size)	3.510 (400)
Prev. Close	4.350
Today's Range	3.450 - 4.740
52wk Range	3.005 - 12.99
Shares Outstanding	19,474,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x

Today 9:25 EDT

Houston, Texas--(Newsfile Corp. - August 12, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) reported encouraging Phase 2a results for intranasal...

Via Newsfile

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

Today 8:00 EDT

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Performance

YTD	-60.7%	-60.7%
1 Month	-19.2%	-19.2%
3 Month	-36.7%	-36.7%
6 Month	-67.4%	-67.4%
1 Year	-31.7%	-31.7%

More News

NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence

August 11, 2026

Via Newsfile

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

August 10, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

August 10, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors

July 27, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition

July 15, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

June 23, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy

June 22, 2026

Via Newsfile

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

June 16, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates

June 15, 2026

Via Newsfile

The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade

June 09, 2026

Via Newsfile

NeOnc Provides Business Update and Reports Q1 2026 Financial Results

May 18, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts

May 05, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics

April 18, 2026

Via ACCESS Newswire

NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results

April 14, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Provides Business Update and Reports Q4 2025 Financial Results

April 01, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints David Choi as Chief Accounting Officer

March 13, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)

March 12, 2026

Via Newsfile

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET

March 04, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity

February 27, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America

February 21, 2026

Via ACCESS Newswire

New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)

February 14, 2026

Via ACCESS Newswire

New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America

February 07, 2026

Via ACCESS Newswire

New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America

January 31, 2026

Via ACCESS Newswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?

Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.

What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?

NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?

The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market

What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?

The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 3.490

When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?

The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 08/12/26 01:23 PM ET

What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?

The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 67.97M

How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?

NeOnc Technologies Holdings, Inc. - Common Stock has 68M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.